1. The out-of-field dose in radiation therapy induces delayed tumorigenesis by senescence evasion.
- Author
-
Goy, Erwan, Tomezak, Maxime, Facchin, Caterina, Martin, Nathalie, Bouchaert, Emmanuel, Benoit, Jerome, de Schutter, Clementine, Nassour, Joe, Saas, Laure, Drullion, Claire, Brodin, Priscille M., Vandeputte, Alexandre, Molendi-Coste, Olivier, Pineau, Laurent, Goormachtigh, Gautier, Pluquet, Olivier, Pourtier, Albin, Cleri, Fabrizio, Lartigau, Eric, and Penel, Nicolas
- Subjects
- *
RADIOTHERAPY , *SINGLE-strand DNA breaks , *RADIATION doses , *NEOPLASTIC cell transformation , *CANCER prevention - Abstract
A rare but severe complication of curative-intent radiation therapy is the induction of second primary cancers. These cancers preferentially develop not inside the planning target volume (PTV) but around, over several centimeters, after a latency period of 1-40 years. We show here that normal human or mouse dermal fibroblasts submitted to the out-of-field dose scattering at the margin of a PTV receiving a mimicked patient's treatment do not die but enter in a long-lived senescent state resulting from the accumulation of unrepaired DNA single-strand breaks, in the almost absence of double-strand breaks. Importantly, a few of these senescent cells systematically and spontaneously escape from the cell cycle arrest after a while to generate daughter cells harboring mutations and invasive capacities. These findings highlight single-strand break-induced senescence as the mechanism of second primary cancer initiation, with clinically relevant spatiotemporal specificities. Senescence being pharmacologically targetable, they open the avenue for second primary cancer prevention. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF